ITabMed Co., Ltd.
ITabMed Co., Ltd.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Recruiting | Early phase 1 | 2026-01-16 | NCT07347860 | |
| Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Phase 1 | 2025-09-17 | NCT06400537 | |
| An Exploratory Study of A-337 in the Management of Malignant Solid Dose Escalation and Expansion Phases | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Not yet recruiting | Phase 1 | 2023-10-23 | NCT06093698 |